Double-blinded randomized controlled trial of Erbium-YAG Laser to treat Female Stress Urinary Incontinence

Urinary Incontinence

Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

J Urol

Takahashi S, Kato K, Yokoyama O, Takei M, Gotoh M

doi: 10.1097/JU.0000000000004024

Further Publications Urology

Is There a Winner? Prospective Randomized Controlled Trial Comparing SuperPulse Thulium Fiber Laser vs Pulse-Modulated High-Power Holmium:YAG Laser for Retrograde Intrarenal Surgery

J Urol

Gupta K, Ricapito A, Connors C, Khargi R, Yaghoubian AJ, Gallante B, Atallah WM, Gupta M

doi: 10.1097/JU.0000000000004310

Overactive BladderUrinary Incontinence

Gene Therapy With URO-902 (pVAX/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial

J Urol

Enemchukwu EA, Kalota S, Robertson K, Ge S, Lu J, Badger H, Mujais S, Peters KM

doi: 10.1097/JU.0000000000004373

Further Publications Urology

The effect of combination treatment with low-intensity shockwave therapy and daily tadalafil on severe erectile dysfunction: a double-blind, randomized, sham-controlled clinical trial

J Sex Med

Kalyvianakis D, Mykoniatis I, Pyrgidis N, Kapoteli P, Zilotis F, Hatzichristou D

doi: 10.1093/jsxmed/qdae038

Urinary Incontinence

Evaluation and Management of Female Stress Urinary Incontinence

Mayo Clin Proc

Jefferson FA, Linder BJ

doi: 10.1016/j.mayocp.2024.07.003

Urinary Incontinence

Intravaginal electrical stimulation of the pelvic floor for women with urinary incontinence - a systematic review of randomised controlled trials

Am J Obstet Gynecol

Naidu D, Modi R, Kulkarni M, Gunasaegaram V, Rolnik DL, Freites J, Vereeck S, Pendharkar G, Webb J, Rosamilia A, Gargett CE, Omar MI, Mol BW, Warty RR

doi: 10.1016/j.ajog.2025.03.017

Benign Prostatic Hyperplasia (BPH)

Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial

J Urol

Staskin D, Owens-Grillo J, Thomas E, Rovner E, Cline K, Mujais S

doi: 10.1097/JU.0000000000003999

Further Publications Gynecology

Safety of topical sildenafil cream, 3.6% in a randomized, placebo-controlled trial for the treatment of female sexual arousal disorder

J Sex Med

Thurman AR, Johnson I, Cornell KA, Hatheway J, Kim NN, Parish SJ, Dart C, Friend DR, Goldstein A

doi: 10.1093/jsxmed/qdae089

Reproductive Health

Efficacy and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: A multicenter, placebo-controlled, double-blind, randomized study

Fertil Steril

Osuga Y, Kobayashi T, Hirakawa A, Takayanagi T, Nogami M, Tayzar K, Mochiyama T, Hirayama M, Foidart JM, Harada T

doi: 10.1016/j.fertnstert.2024.11.003

Related content

Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

Is There a Winner? Prospective Randomized Controlled Trial Comparing SuperPulse Thulium Fiber Laser vs Pulse-Modulated High-Power Holmium:YAG Laser for Retrograde Intrarenal Surgery

Gene Therapy With URO-902 (pVAX/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial

The effect of combination treatment with low-intensity shockwave therapy and daily tadalafil on severe erectile dysfunction: a double-blind, randomized, sham-controlled clinical trial

Evaluation and Management of Female Stress Urinary Incontinence

Intravaginal electrical stimulation of the pelvic floor for women with urinary incontinence - a systematic review of randomised controlled trials

Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial

Safety of topical sildenafil cream, 3.6% in a randomized, placebo-controlled trial for the treatment of female sexual arousal disorder

Efficacy and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: A multicenter, placebo-controlled, double-blind, randomized study